Literature DB >> 7656343

Psoriatic arthritis.

D D Gladman1.   

Abstract

Despite the fact that psoriatic arthritis has been recognized as an entity for almost five decades, there are still no valid criteria for either its diagnosis or classification. Several sets of criteria have been proposed but none was studied. None the less, investigators have been able to study the condition and describe its unique features and its natural course and prognosis. However, in order to facilitate further studies, it would be worthwhile to develop an internationally accepted and validated set of criteria, both for the diagnosis and classification of the disease, as well as for the assessment of damage. These criteria would help set up appropriate therapeutic trials in this condition as well.

Entities:  

Mesh:

Year:  1995        PMID: 7656343     DOI: 10.1016/s0950-3579(05)80193-1

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN: 0950-3579


  11 in total

1.  Prevalence of patient-reported comorbidities in early and established psoriatic arthritis cohorts.

Authors:  Majed Khraishi; Don MacDonald; Emmanouil Rampakakis; Julie Vaillancourt; John S Sampalis
Journal:  Clin Rheumatol       Date:  2011-02-02       Impact factor: 2.980

2.  MRI in psoriatic arthritis with hand and foot involvement.

Authors:  Nadir Ghanem; Markus Uhl; Gregor Pache; Thorsten Bley; Ulrich A Walker; Mathias Langer
Journal:  Rheumatol Int       Date:  2006-10-07       Impact factor: 2.631

3.  Presentation of psoriatic arthritis in the literature: a twenty-year bibliometric evaluation.

Authors:  Ahmad-Reza Jamshidi; Farhad Gharibdoost; Abdolhadi Nadji; Mohammadali Nikou; Gholamreza Habibi; Amirhossein Mardani; Marjan Ghaemi
Journal:  Rheumatol Int       Date:  2012-03-27       Impact factor: 2.631

4.  Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q.

Authors:  H B Yeon; N M Lindor; J G Seidman; C E Seidman
Journal:  Am J Hum Genet       Date:  2000-03-21       Impact factor: 11.025

5.  Rheumatic manifestations of psoriasis.

Authors:  H A Sadek; A M Abdel-Nasser; T A El-Amawy; S Z Hassan
Journal:  Clin Rheumatol       Date:  2006-05-03       Impact factor: 2.980

Review 6.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome.

Authors:  D D Gladman; C Antoni; P Mease; D O Clegg; P Nash
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

7.  Dactylitis in psoriatic arthritis: a marker for disease severity?

Authors:  J E Brockbank; M Stein; C T Schentag; D D Gladman
Journal:  Ann Rheum Dis       Date:  2004-07-22       Impact factor: 19.103

8.  Switching tumour necrosis factor alpha antagonists in patients with ankylosing spondylitis and psoriatic arthritis: an observational study over a 5-year period.

Authors:  Fabrizio Conti; Fulvia Ceccarelli; Elisa Marocchi; Leonardo Magrini; Francesca Romana Spinelli; Antonio Spadaro; Rossana Scrivo; Guido Valesini
Journal:  Ann Rheum Dis       Date:  2007-07-05       Impact factor: 19.103

9.  Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies.

Authors:  Amr A Saad; Darren M Ashcroft; Kath D Watson; Deborah P M Symmons; Peter R Noyce; Kimme L Hyrich
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-03       Impact factor: 4.794

10.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.